Table 2.
SF-36 outcomesa
| Measure b | MOR group | AR group | ||||
|---|---|---|---|---|---|---|
| Baseline | Six months | Latest follow-upc | Baseline | Six months | Latest follow-upc | |
| Physical functioning | 45.0 (5.39; 43.1–46.9) | 53.3 (7.9; 50.4–56.1) | 65.1 (5.1; 63.3–66.9) | 45.0 (5.6; 43.0–47.0) | 51.5 (5.4; 49.6–53.4) | 66.7 (4.3; 65.1–68.2) |
| Role physical | 24.3 (4.7; 22.6–26.0) | 37.2 (7.9; 34.3–40.0) | 48.7 (7.1; 46.1–51.2) | 23.8 (2.9; 22.7–24.8) | 39.1 (7.7; 36.3–41.9) | 50.0 (5.5; 48.0–52.0) |
| Bodily pain | 32.0 (4.1; 30.5–33.5) | 44.6 (9.6 ; 7.7–12.8) | 58.5 (6.1; 56.3–60.7) | 30.3 (4.0; 28.9–31.8) | 47.7 (7.1; 45.1–50.2) | 59.3 (4.5; 57.7–61.0) |
| General health | 23.1 (3.4; 21.9–24.4) | 37.0 (8.7; 33.9–40.2) | 49.5 (5.3; 47.6–51.4) | 22.5 (2.9; 21.5–23.6) | 34.7 (6.9; 32.2–37.2) | 48.5 (5.0; 46.7–50.3) |
| Vitality | 43.1 (4.2; 41.6–44.7) | 47.0 (4.1; 45.5–48.4) | 53.3 (3.8; 51.9–54.7) | 42.4 (4.4; 40.8–44.0) | 46.0 (5.5; 44.0–47.9) | 50.5 (7.3; 47.9–53.2) |
| Social functioning | 51.3 (3.9; 49.9–52.7) | 57.6 (5.0; 55.8–59.4) | 69.2 (4.6; 67.5–70.8) | 50.1 (4.8, 48.3–51.8) | 58.4 (6.7; 56.0–60.8) | 67.9 (4.2; 66.4–69.4) |
| Role emotional | 41.5 (5.4; 39.6–43.5) | 51.5 (6.7; 49.1–53.99 | 67.7 (5.6; 65.7–69.7) | 42.1 (5.8; 40.0–44.2) | 49.7 (6.0; 47.5–51.9) | 66.8 (5.1; 64.9–68.6) |
| Mental health | 48.7 (4.2; 47.2–50.2) | 54.7 (4.9; 53.0–56.5) | 61.3 (5.2; 59.4–63.1) | 48.5 (6.1; 46.3–50.7) | 52.8 (5.1; 50.9–54.6) | 58.2 (8.5; 55.1–61.3) |
a Analysed using repeated-measures analysis of variance. The values given as mean score (SD; 95% CI)
b No group to group differences preoperatively and at latest follow-up (P > 0.05)
cP < 0.001 between baseline and latest follow-up